MedPath

Nexgen Dermatologics, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 1
1 (33.3%)

The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

Not Applicable
Recruiting
Conditions
Dermatitis, Atopic
Pruritus
First Posted Date
2024-07-05
Last Posted Date
2024-07-05
Lead Sponsor
Nexgen Dermatologics, Inc.
Target Recruit Count
60
Registration Number
NCT06488742
Locations
🇺🇸

Berlin Center, Boynton Beach, Florida, United States

A Novel Combination Oral Agent to Treat Acne Vulgaris

Phase 1
Conditions
ACNE VULGARIS
Interventions
First Posted Date
2011-02-23
Last Posted Date
2011-02-23
Lead Sponsor
Nexgen Dermatologics, Inc.
Target Recruit Count
60
Registration Number
NCT01301586
Locations
🇺🇸

Palos Verdes Dermatology Associates, Rolling Hills Estates, California, United States

🇺🇸

Berlin Center, Boynton Beach, Florida, United States

A Novel Oral Natural Extract for the Treatment of Senile Purpura

Not Applicable
Conditions
PURPURA
First Posted Date
2010-08-18
Last Posted Date
2011-06-08
Lead Sponsor
Nexgen Dermatologics, Inc.
Target Recruit Count
75
Registration Number
NCT01183910
Locations
🇺🇸

Berlin Center of Medical Aesthetics, Boynton Beach, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.